“Later, we will see the safety data, the percentage of side effects. What is important is the usefulness, the enhancing power immunity How, measurement, we will do for the approval data whether the vaccine is suitable for use. This must be maintained so that the data is valid and used for EUA, “said Lucia in the ‘Continuation of Clinical Trial of the COVID-19 Vaccine’ on FMB9, Wednesday (21/10).
– .
